A survival analysis of hospitalization among patients with acquired immunodeficiency syndrome.
Survival analysis techniques were used in estimating lifetime inpatient utilization among patients diagnosed with acquired immunodeficiency syndrome (AIDS) using data on 863 members of the Kaiser Permanente Medical Care Program in the Northern California Region diagnosed with AIDS between January 1, 1981 and June 30, 1987. Using information on both deceased and living patients, we estimated means of 40.3 lifetime inpatient days and 3.3 hospitalizations among all AIDS patients. Those presenting with Kaposi's sarcoma experienced a mean of 7.6 fewer lifetime inpatient days than those presenting with Pneumocystis carinii pneumonia (95% confidence interval = .61, 14.6) and a mean of 11.0 (3.9, 18.6) fewer inpatient days than all other AIDS patients. Older patients had fewer hospital admissions than younger ones. Year of diagnosis does not appear to be related to lifetime utilization, and there is an indication that increased survival has been accompanied by decreased inpatient utilization intensity as measured on a per person-year basis. We recommend the use of survival analysis methods in the study of utilization among groups of patients with incomplete follow-up.
Quesenberry
C P
CP
Division of Research, Kaiser Permanente Medical Care Program, Oakland, CA 94611.
Fireman
B
B
Hiatt
R A
RA
Selby
J V
JV
D000163:Acquired Immunodeficiency Syndrome / Q000401:mortality; D000328:Adult; D002140:California / Q000453:epidemiology; D005260:Female; D006760:Hospitalization / Q000706:statistics & numerical data*; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections; D011020:Pneumonia, Pneumocystis; D012514:Sarcoma, Kaposi; D016019:Survival Analysis; D013997:Time Factors